User profiles for Peter R Schofield

Peter R Schofield

Neuroscience Research Australia
Verified email at neura.edu.au
Cited by 66290

Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

…, PR Dodd, N Hayward, JBJ Kwok, PR Schofield… - Nature, 1998 - nature.com
Thirteen families have been described with an autosomal dominantly inherited dementia
named frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) 1 , 2 , 3 …

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

…, JM Ringman, MN Rossor, PR Schofield… - … England Journal of …, 2012 - Mass Medical Soc
Background The order and magnitude of pathologic processes in Alzheimer's disease are
not well understood, partly because the disease develops over many years. Autosomal …

Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor super-family

PR Schofield, MG Darlison, N Fujita, DR Burt… - Nature, 1987 - nature.com
Amino-acid sequences derived from complementary DMAs encoding the α- and β-subunits
of the GAB A/ benzo diazepine receptor from bovine brain show homology with other ligand-…

Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology

…, BD Shivers, S Ymer, H Kettenmann, PR Schofield… - Nature, 1989 - nature.com
NEUROTRANSMISSION effected by GABA (γ-aminobutyric acid) is predominantly mediated
by a gated chloride channel intrinsic to the GABA A receptor. This heterooligomeric receptor …

Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease

…, J Levin, CL Masters, R Martins, PR Schofield… - Nature medicine, 2019 - nature.com
Neurofilament light chain (NfL) is a promising fluid biomarker of disease progression for
various cerebral proteopathies. Here we leverage the unique characteristics of the Dominantly …

A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease

…, NR Graff-Radford, S Salloway, PR Schofield… - Nature medicine, 2020 - nature.com
Abstract Development of tau-based therapies for Alzheimer’s disease requires an understanding
of the timing of disease-related changes in tau. We quantified the phosphorylation state …

[PDF][PDF] Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder

…, G Turecki, S Claes, JR Kelsoe, PR Schofield… - The American Journal of …, 2003 - cell.com
Genome scans of bipolar disorder (BPD) have not produced consistent evidence for linkage.
The rank-based genome scan meta-analysis (GSMA) method was applied to 18 BPD …

The genetic architecture of the human cerebral cortex

…, F Schlag, L Schmaal, PR Schofield, R Secolin… - Science, 2020 - science.org
INTRODUCTION The cerebral cortex underlies our complex cognitive capabilities.
Variations in human cortical surface area and thickness are associated with neurological, …

Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis

…, JM Ringman, S Salloway, PR Schofield, R Sperling… - Neurology, 2014 - AAN Enterprises
Objective: To identify factors influencing age at symptom onset and disease course in
autosomal dominant Alzheimer disease (ADAD), and develop evidence-based criteria for …

Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study

…, S Salloway, AJ Saykin, PR Schofield… - The Lancet …, 2018 - thelancet.com
Background Models of Alzheimer's disease propose a sequence of amyloid β (Aβ) accumulation,
hypometabolism, and structural decline that precedes the onset of clinical dementia. …